Sector Gamma As
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$423.5M
Q ending 2026-03-31
Prior quarter
$438.7M
Q ending 2025-12-31
Change
-3.5% QoQ · +35.6% YoY
Positions
42
reported holdings
Largest positions
All 42 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Bristol-Myers Squibb Co | BMY | Shares | $50.2M | 828K |
| Merck & Co Inc | MRK | Shares | $31.3M | 260K |
| Pfizer Inc | PFE | Shares | $30.6M | 1.1M |
| Medtronic Plc | Shares | $24.3M | 281K | |
| Incyte Corp | INCY | Shares | $18.9M | 201K |
| Amgen Inc | AMGN | Shares | $16.6M | 47K |
| Biogen Inc | BIIB | Shares | $16.5M | 90K |
| Zimmer Biomet Holdings Inc | ZBH | Shares | $14.1M | 156K |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $13.6M | 240K |
| Becton Dickinson & Co | BDX | Shares | $13.0M | 83K |
| Elevance Health Inc Formerly | ELV | Shares | $12.9M | 44K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $12.7M | 169K |
| Cardinal Health Inc | CAH | Shares | $11.6M | 55K |
| Unitedhealth Group Inc | UNH | Shares | $9.9M | 36K |
| Cvs Health Corp | CVS | Shares | $9.7M | 135K |
| Bruker Corp | BRKR | Shares | $9.2M | 254K |
| Ge Healthcare Technologies I | GEHC | Shares | $9.0M | 126K |
| Abbott Labs | ABT | Shares | $9.0M | 88K |
| Gilead Sciences Inc | GILD | Shares | $7.4M | 53K |
| Lantheus Hldgs Inc | LNTH | Shares | $7.1M | 93K |
| Iqvia Hldgs Inc | IQV | Shares | $6.9M | 40K |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $6.7M | 286K |
| Bio Rad Labs Inc | BIO | Shares | $6.6M | 24K |
| Qiagen Nv | Shares | $6.5M | 162K | |
| Avantor Inc | AVTR | Shares | $5.5M | 695K |
| Centene Corp Del | CNC | Shares | $5.3M | 162K |
| Tandem Diabetes Care Inc | TNDM | Shares | $5.1M | 267K |
| Ptc Therapeutics Inc | PTCT | Shares | $5.1M | 75K |
| Labcorp Holdings Inc | LH | Shares | $5.1M | 19K |
| Ascendis Pharma A/S | Shares | $4.9M | 21K | |
| Edwards Lifesciences Corp | EW | Shares | $4.8M | 60K |
| Dexcom Inc | DXCM | Shares | $3.5M | 56K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $3.4M | 94K |
| Kura Oncology Inc | KURA | Shares | $3.3M | 412K |
| Humana Inc | HUM | Shares | $3.3M | 19K |
| Bridgebio Pharma Inc | BBIO | Shares | $3.3M | 44K |
| Iovance Biotherapeutics Inc | IOVA | Shares | $3.2M | 900K |
| Denali Therapeutics Inc | DNLI | Shares | $3.1M | 163K |
| Ardelyx Inc | ARDX | Shares | $3.1M | 516K |
| Cogent Biosciences Inc | COGT | Shares | $3.1M | 80K |
| Organon & Co | OGN | Shares | $2.3M | 376K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $1.9M | 30K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.